Overall, GJB2 and GJB3 are constitutively expressed in CRC cell lines, whereas GJA1, GJA3, or GJC3 were found in a subset of lines, presumably due to mutations or stable methylation differences in their promoter regions. Here, GJC3 is linked to colorectal carcinoma.